| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1205478A1 p38MAP KINASE INHIBITORS |
| 05/15/2002 | EP1205182A2 Adenosine as antithrombotic |
| 05/15/2002 | EP1204681A2 Helical cytokine zalpha48 |
| 05/15/2002 | EP1204665A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204626A1 Ether compounds, compositions, and uses thereof |
| 05/15/2002 | EP1204419A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 05/15/2002 | EP1204414A2 Use of morphinan derivates as medicines |
| 05/15/2002 | EP0729460B1 Substituted 5-ring heterocycles, their preparation and their use |
| 05/15/2002 | EP0617623B1 Transdermally administered system containing acetylsalicylic acid for thrombosis therapy |
| 05/15/2002 | CN1349530A 1-(P-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds |
| 05/15/2002 | CN1349526A Prodrugs of thrombin inhibitors |
| 05/15/2002 | CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 05/15/2002 | CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 05/15/2002 | CN1349499A Thio-oxindole derivatives |
| 05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
| 05/15/2002 | CN1348785A Medicine 'Xuewang' for treating anemia |
| 05/15/2002 | CN1348768A 活性山羊血粉胶囊 Activity goat blood meal capsule |
| 05/15/2002 | CN1348763A Medicine composite for preventing or treaitng diseases relating to IL-12 over growth |
| 05/15/2002 | CN1084620C Medicine for prophylaxis and treatment of thromboxane A2-mediated diseases |
| 05/14/2002 | US6387942 Pyrazolyl compound; anticoagulants, antiproliferative agent |
| 05/14/2002 | US6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/14/2002 | US6387916 Administering to humans, animals |
| 05/14/2002 | US6387911 Pyrazinone thrombin inhibitors |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387883 Method for the prevention and treatment of cachexia and anorexia |
| 05/14/2002 | US6387875 Method of use for murine leukaemia inhibitory factor-binding protein (mLBP) |
| 05/14/2002 | US6387612 Method of preparing a terminally heat sterilized plasma-like solution |
| 05/14/2002 | US6387366 Reducing the biological activity of tissue factor, tf; bone marrow cells; antisense oligonucleotide or ribozyme which inhibits expression of tissue factor (tf) or an antibody that binds to and inhibits tf |
| 05/14/2002 | CA2167090C Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 05/14/2002 | CA2086323C Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/10/2002 | WO2002036798A2 Inhibitors of transglutaminases |
| 05/10/2002 | WO2002036761A2 Compositions and methods for the diagnosis of cancer |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036634A2 Gene regulation therapy involving ferritin |
| 05/10/2002 | WO2002036631A1 Method of screening antiplatelet |
| 05/10/2002 | WO2002036626A1 Single-chain multimeric polypeptides |
| 05/10/2002 | WO2002036593A1 Indole derivatives as pde5-inhibitors |
| 05/10/2002 | WO2002036590A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 05/10/2002 | WO2002036543A1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride |
| 05/10/2002 | WO2002036161A2 Novel targeted compositions for diagnostic and therapeutic use |
| 05/10/2002 | WO2002036155A1 Use of blood coagulation factor xiii for treating haemophilia a |
| 05/10/2002 | WO2002036152A1 Use of il-1 inhibitors and tnf antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia |
| 05/10/2002 | WO2002036151A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 05/10/2002 | WO2002035942A1 Food grade transglutaminase inhibitor and uses thereof |
| 05/10/2002 | WO2002016381A3 Composition and method for inhibiting platelet aggregation |
| 05/10/2002 | WO2002016338A8 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 05/10/2002 | WO2001090316A3 Human circulating dendritic cell compositions and methods |
| 05/10/2002 | WO2001089564A3 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity |
| 05/10/2002 | WO2001085201A3 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 05/10/2002 | WO2001082919A3 Methods of and compounds for inhibiting calpains |
| 05/10/2002 | WO2001079288A3 Cytokine uses; compositions; methods |
| 05/10/2002 | WO2001076639A3 Chemically-modified myelopoietin conjugates |
| 05/10/2002 | WO2001068697A3 Methods and compositions for immunoregulation |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |
| 05/10/2002 | WO2001066594A3 Human protein kinases and protein kinase-like enzymes |
| 05/10/2002 | WO2001064879A3 G-proteins coupled receptor related polypeptides |
| 05/10/2002 | WO2001064236A3 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS |
| 05/10/2002 | WO2001047963A3 Inhibitors of complement activation, their preparation and use |
| 05/10/2002 | WO2001032709A3 Polypeptides with non-natural primary signalling motifs |
| 05/10/2002 | WO2001023389A3 Certain alkylene diamine-substituted heterocycles |
| 05/10/2002 | WO2000058339A3 50 human secreted proteins |
| 05/10/2002 | WO2000050639A3 Gene sequence variations with utility in determining the treatment of disease |
| 05/10/2002 | CA2428606A1 Novel targeted compositions for diagnostic and therapeutic use |
| 05/10/2002 | CA2427802A1 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof |
| 05/10/2002 | CA2427629A1 Gene regulation therapy involving ferritin |
| 05/10/2002 | CA2427535A1 Use of blood coagulation factor xiii for treating haemophilia a |
| 05/10/2002 | CA2427533A1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 05/10/2002 | CA2427518A1 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | CA2427394A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 05/10/2002 | CA2427193A1 Food grade transglutaminase inhibitor and uses thereof |
| 05/10/2002 | CA2425842A1 Use of il-1 inhibitors and tnf antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia |
| 05/10/2002 | CA2395324A1 Expression potentiator for protein synthesis regulatory gene |
| 05/09/2002 | WO2002036153A1 Expression potentiator for protein synthesis regulatory gene |
| 05/09/2002 | US20020055632 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction |
| 05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/09/2002 | US20020055507 Ureas and thioureas inhibit production of cytokines |
| 05/09/2002 | US20020055469 Anticoagulants |
| 05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
| 05/09/2002 | US20020054924 Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor |
| 05/08/2002 | EP1203026A1 Binding moieties for fibrin |
| 05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 05/08/2002 | EP1203014A2 Peptide antagonists of factor viia |
| 05/08/2002 | EP1203010A1 Antisense modulation of fadd expression |
| 05/08/2002 | EP1203007A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1202989A1 Benzamide derivatives |
| 05/08/2002 | EP1202988A2 Novel integrin receptor antagonists |
| 05/08/2002 | EP1202975A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/08/2002 | EP1202967A2 Sulfuric acid mono-[3-((1-(2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl)-hydroxy-methyl)-2-methoxy-phenyl]ester |
| 05/08/2002 | EP1202965A1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 05/08/2002 | EP1202964A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 05/08/2002 | EP1202959A1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 05/08/2002 | EP1202953A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 05/08/2002 | EP1202744A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 05/08/2002 | EP1202738A1 Dihydropyrazine derivatives as npy antagonists |
| 05/08/2002 | EP0804464B1 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 05/08/2002 | CN1348446A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
| 05/08/2002 | CN1348444A 丝氨酸蛋白酶抑制剂 Serine protease inhibitors |
| 05/08/2002 | CN1348363A Novel pharmaceutical salt form |